Cargando…
Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins
Sphingolipids are bioactive lipids associated with cellular membranes and plasma lipoproteins, and their synthesis and degradation are tightly regulated. We have previously determined that low plasma concentrations of certain ceramide species predict the development of nephropathy in diabetes patien...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073971/ https://www.ncbi.nlm.nih.gov/pubmed/32045989 http://dx.doi.org/10.3390/genes11020178 |
_version_ | 1783506732136267776 |
---|---|
author | Hammad, Samar M. Twal, Waleed O. Arif, Ehtesham Semler, Andrea J. Klein, Richard L. Nihalani, Deepak |
author_facet | Hammad, Samar M. Twal, Waleed O. Arif, Ehtesham Semler, Andrea J. Klein, Richard L. Nihalani, Deepak |
author_sort | Hammad, Samar M. |
collection | PubMed |
description | Sphingolipids are bioactive lipids associated with cellular membranes and plasma lipoproteins, and their synthesis and degradation are tightly regulated. We have previously determined that low plasma concentrations of certain ceramide species predict the development of nephropathy in diabetes patients with normal albumin excretion rates at baseline. Herein, we tested the hypothesis that altering the sphingolipid content of circulating lipoproteins can alter the metabolic and signaling pathways in podocytes, whose dysfunction leads to an impairment of glomerular filtration. Cultured human podocytes were treated with lipoproteins from healthy subjects enriched in vitro with C16 ceramide, or D-erythro 2-hydroxy C16 ceramide, a ceramide naturally found in skin. The RNA-Seq data demonstrated differential expression of genes regulating sphingolipid metabolism, sphingolipid signaling, and mTOR signaling pathways. A multiplex analysis of mTOR signaling pathway intermediates showed that the majority (eight) of the pathway phosphorylated proteins measured (eleven) were significantly downregulated in response to C16 ceramide-enriched HDL2 compared to HDL2 alone and hydroxy ceramide-enriched HDL2. In contrast, C16 ceramide-enriched HDL3 upregulated the phosphorylation of four intermediates in the mTOR pathway. These findings highlight a possible role for lipoprotein-associated sphingolipids in regulating metabolic and signaling pathways in podocytes and could lead to novel therapeutic targets in glomerular kidney diseases. |
format | Online Article Text |
id | pubmed-7073971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70739712020-03-19 Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins Hammad, Samar M. Twal, Waleed O. Arif, Ehtesham Semler, Andrea J. Klein, Richard L. Nihalani, Deepak Genes (Basel) Article Sphingolipids are bioactive lipids associated with cellular membranes and plasma lipoproteins, and their synthesis and degradation are tightly regulated. We have previously determined that low plasma concentrations of certain ceramide species predict the development of nephropathy in diabetes patients with normal albumin excretion rates at baseline. Herein, we tested the hypothesis that altering the sphingolipid content of circulating lipoproteins can alter the metabolic and signaling pathways in podocytes, whose dysfunction leads to an impairment of glomerular filtration. Cultured human podocytes were treated with lipoproteins from healthy subjects enriched in vitro with C16 ceramide, or D-erythro 2-hydroxy C16 ceramide, a ceramide naturally found in skin. The RNA-Seq data demonstrated differential expression of genes regulating sphingolipid metabolism, sphingolipid signaling, and mTOR signaling pathways. A multiplex analysis of mTOR signaling pathway intermediates showed that the majority (eight) of the pathway phosphorylated proteins measured (eleven) were significantly downregulated in response to C16 ceramide-enriched HDL2 compared to HDL2 alone and hydroxy ceramide-enriched HDL2. In contrast, C16 ceramide-enriched HDL3 upregulated the phosphorylation of four intermediates in the mTOR pathway. These findings highlight a possible role for lipoprotein-associated sphingolipids in regulating metabolic and signaling pathways in podocytes and could lead to novel therapeutic targets in glomerular kidney diseases. MDPI 2020-02-07 /pmc/articles/PMC7073971/ /pubmed/32045989 http://dx.doi.org/10.3390/genes11020178 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hammad, Samar M. Twal, Waleed O. Arif, Ehtesham Semler, Andrea J. Klein, Richard L. Nihalani, Deepak Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins |
title | Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins |
title_full | Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins |
title_fullStr | Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins |
title_full_unstemmed | Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins |
title_short | Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins |
title_sort | transcriptomics reveal altered metabolic and signaling pathways in podocytes exposed to c16 ceramide-enriched lipoproteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073971/ https://www.ncbi.nlm.nih.gov/pubmed/32045989 http://dx.doi.org/10.3390/genes11020178 |
work_keys_str_mv | AT hammadsamarm transcriptomicsrevealalteredmetabolicandsignalingpathwaysinpodocytesexposedtoc16ceramideenrichedlipoproteins AT twalwaleedo transcriptomicsrevealalteredmetabolicandsignalingpathwaysinpodocytesexposedtoc16ceramideenrichedlipoproteins AT arifehtesham transcriptomicsrevealalteredmetabolicandsignalingpathwaysinpodocytesexposedtoc16ceramideenrichedlipoproteins AT semlerandreaj transcriptomicsrevealalteredmetabolicandsignalingpathwaysinpodocytesexposedtoc16ceramideenrichedlipoproteins AT kleinrichardl transcriptomicsrevealalteredmetabolicandsignalingpathwaysinpodocytesexposedtoc16ceramideenrichedlipoproteins AT nihalanideepak transcriptomicsrevealalteredmetabolicandsignalingpathwaysinpodocytesexposedtoc16ceramideenrichedlipoproteins |